Human Growth Hormone (HGH), also known as somatropin, is a 191-amino acid peptide hormone naturally secreted by the anterior pituitary gland. It is one of the most extensively studied hormones in endocrinology, with a research history spanning decades of investigation into its effects on cell growth, protein synthesis, fat metabolism, and tissue regeneration. Unlike growth hormone secretagogues, which stimulate the body's own pituitary output, HGH research typically administers the hormone directly, allowing researchers to study its downstream effects independent of endogenous regulatory feedback.

What Is HGH?

HGH is synthesized and secreted by somatotroph cells in the anterior pituitary in a pulsatile pattern, with secretion peaking during deep sleep and in response to exercise, fasting, and stress. Recombinant HGH (191AA), first developed in the 1980s, replicates the exact amino acid sequence of endogenous human growth hormone, making it a widely used research tool for studying growth hormone physiology without the manufacturing inconsistency associated with earlier cadaver-derived preparations. Its actions are mediated both directly through growth hormone receptors and indirectly through stimulation of insulin-like growth factor 1 (IGF-1) production, primarily in the liver.

Mechanisms of Action

Growth Hormone Receptor Signalling

HGH exerts its effects by binding to growth hormone receptors expressed on the surface of cells throughout the body, most densely in the liver, muscle, adipose tissue, and bone. Receptor binding activates the JAK2-STAT5 signalling pathway, which drives transcription of genes involved in cell growth, protein synthesis, and metabolic regulation. This direct signalling pathway distinguishes HGH from many other peptides in that its downstream effects are mediated by a well-characterized, receptor-specific cascade rather than diffuse cellular interactions.

IGF-1 Mediation

A substantial portion of HGH's growth-promoting activity is mediated indirectly through stimulation of hepatic IGF-1 production. IGF-1 circulates systemically and acts on IGF-1 receptors in skeletal muscle, cartilage, and other tissues to promote cellular proliferation and protein synthesis. Because of this relationship, IGF-1 levels are frequently used in research as a biomarker of growth hormone activity, providing a more stable, integrated measure than the highly pulsatile secretion pattern of HGH itself.

Lipolysis and Fat Metabolism

HGH has well-documented lipolytic effects, promoting the breakdown of stored triglycerides in adipose tissue and shifting metabolic substrate utilisation toward fat oxidation. Research has consistently shown that HGH administration reduces fat mass, particularly visceral adiposity, while sparing lean tissue — a metabolic profile that has made it a compound of significant interest in body composition and metabolic research.

Protein Synthesis and Nitrogen Retention

Beyond its indirect IGF-1-mediated effects, HGH promotes amino acid uptake into skeletal muscle and enhances nitrogen retention, supporting a net anabolic state. This has made HGH a key subject of research into recovery from catabolic states, including severe illness, burns, and age-related muscle wasting (sarcopenia).

Research Applications

Body Composition and Lean Mass Research

Clinical and preclinical research has repeatedly demonstrated that HGH administration in growth hormone-deficient populations improves lean body mass while reducing fat mass. This body composition effect has extended interest into research on age-related decline in growth hormone secretion — sometimes referred to as the somatopause — and its contribution to sarcopenia and increased visceral fat in older adults.

Recovery and Tissue Repair Research

Because of its anabolic and pro-regenerative properties, HGH has been studied extensively in models of recovery from injury, surgery, and catabolic illness. Research has explored its role in wound healing, bone density maintenance, and connective tissue repair, often in combination with resistance exercise protocols to assess synergistic effects on musculoskeletal recovery.

Age-Related Growth Hormone Decline

Growth hormone secretion is known to decline progressively with age, and a substantial body of research has investigated whether restoring more youthful GH/IGF-1 levels can mitigate aspects of age-related physical decline. Landmark studies, including work published in the *New England Journal of Medicine*, reported improvements in lean body mass, skin thickness, and bone density in older adults receiving HGH, though findings on functional outcomes and long-term safety remain an active area of ongoing research and academic debate.

HGH vs Growth Hormone Secretagogues

HGH research is often discussed alongside growth hormone secretagogues such as Ipamorelin, Tesamorelin, and the CJC-1295 & Ipamorelin combination. The key distinction is mechanistic: HGH is the growth hormone molecule itself, administered directly and bypassing the pituitary gland entirely, whereas secretagogues act upstream to stimulate the pituitary's own pulsatile release of growth hormone. Because direct HGH administration produces a sustained, non-pulsatile elevation in circulating hormone, research models frequently report more immediate and pronounced increases in IGF-1 compared to secretagogue-based approaches, which preserve the body's natural feedback regulation.

Conclusion

Few compounds in peptide research carry as extensive and well-characterized a research history as Human Growth Hormone. Its direct receptor-mediated signalling, IGF-1 dependent growth effects, and pronounced influence on fat and protein metabolism make it a foundational reference point for endocrine and metabolic research, and a frequent comparator for newer growth hormone secretagogues. Researchers interested in the secretagogue approach to growth hormone research can read our articles on Ipamorelin and Tesamorelin.

Available in Malaysia: HGH is stocked locally by Concept Peptides, with third-party COA testing and 1–3 business day delivery nationwide. See our guide on how to buy HGH in Malaysia for pricing and sourcing details.

Research HGH today
Shop HGH

References

  1. Rudman D, Feller AG, Nagraj HS, et al. "Effects of human growth hormone in men over 60 years old." New England Journal of Medicine. 1990.
  2. Vance ML, Mauras N. "Growth hormone therapy in adults and children." New England Journal of Medicine. 1999.
  3. Liu H, Bravata DM, Olkin I, et al. "Systematic review: the safety and efficacy of growth hormone in the healthy elderly." Annals of Internal Medicine. 2007.
  4. Møller N, Jørgensen JO. "Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects." Endocrine Reviews. 2009.